Medistem to Provide Update on Heart Failure Clinical Trial at Noble Life...
Adult Stem Cell Company Announces Presentation and Cell Therapy Panel Participation SAN DIEGO–(BUSINESS WIRE)– Medistem Inc (Pink Sheets:MEDS), a clinical stage adult stem cell company, today announced...
View ArticleMedistem and Superview Biotechnology Co. Ltd. Initiate Collaboration on...
SAN DIEGO–(BUSINESS WIRE)– Medistem Inc (Pink Sheets:MEDS) announced today the initiation of a collaboration with Superview Biotechnology Co. Ltd, a subsidiary of Yinhuan Holding Co from Yixing, China....
View ArticleChina Biotech In Review: Sanofi, Sinopharm To Conduct Joint Research Into...
Fosun Pharma’s (SHA: 600196) long-in-the-works IPO on the Hong Kong exchange is scheduled to take place this month, raising a diminished $600 million. The company received regulatory approval for the...
View ArticleBiopharmaceutical Executive Dr. Alan Lewis Appointed as CEO of Medistem
World-Class Industry Expert to Accelerate Commercialization of Universal Donor Stem Cell Drug for Heart Failure, Critical Limb Ischemia and Type 1 Diabetes SAN DIEGO–(BUSINESS WIRE)– Medistem Inc....
View ArticleNIH Data Suggests Medistem’s Stem Cell is Unique from Competitor Stem Cells
SAN DIEGO–(BUSINESS WIRE)– Medistem Inc. (PINKSHEETS: MEDS) announced today a peer-reviewed publication led by NIH scientists demonstrating that the company’s Endometrial Regenerative Cells (ERC)...
View ArticleMedistem CEO Dr. Alan Lewis to Present at the Stem Cell Meeting on the Mesa
Company to Discuss Clinical Trials using Menstrual Blood Derived Stem Cells for Treating Cardiovascular Disease SAN DIEGO–(BUSINESS WIRE)– Medistem announced today Dr. Alan Lewis, the recently...
View ArticleUrologic Surgery Pioneer Dr. Alexander Gershman Joins Medistem’s Scientific...
Endometrial Stem Cell Company Expands Clinical Applications of Its Universal Donor Stem Cell Product SAN DIEGO, CA–(Marketwire – Nov 19, 2012) – Medistem ( PINKSHEETS : MEDS ) announced today...
View ArticleMedistem Inc. Annual Letter to Shareholders
Dear Fellow Shareholders, 2012 was marked by significant progress in the development of the Endometrial Regenerative Cell (ERC), our new universal donor “stem cell drug.” Most significantly, we...
View ArticleMedistem Inc. Appoints Biotechnology Veteran John Chiplin, Ph.D. to Board of...
SAN DIEGO, CA–(Marketwire – Jan 8, 2013) – Medistem Inc. ( PINKSHEETS : MEDS ), announced today that John Chiplin, Ph.D., has been elected to its Board of Directors. Dr. Chiplin has over 25 years of...
View ArticleMenstrual Blood Stem Cells Used to Treat Heart Failure Patients
Peer-Reviewed Publication Reports on Medistem’s Ongoing Phase II Trial SAN DIEGO, CA–(Marketwire – Mar 22, 2013) – Medistem Inc. ( PINKSHEETS : MEDS ) announced today it published an update on its...
View Article
